Wednesday 12 November
Foyer - Level S1 Meeting registration
PLENARY SESSIONS
Amphi. Gaston Berger - Level S2Welcome Introduction
- Daniel OLIVE - SFI President
Amphi. Gaston Berger - Level S2Pierre Grabar* Keynote Lecture
* Cofounder and 1st President of the SFI
Chair: Emmanuelle JOUANGUY (Paris, France)
-  Jean-Laurent CASANOVA (Human Genetics of Infectious diseases, Rockefeller University, New York, USA, Imagine institute, Necker Hospital for Sick Children, Paris, France)
 Human genetics of infectious diseases
Amphi. Gaston Berger - Level S2SESSION 1 - Tolerance / Autoimmunity
Chairs: Marianne BURBAGE (Paris, France) & Anne ASTIER (Toulouse, France)
- Carola	VINUESA (The Francis Crick Institute, London, UK)
 Title upcoming
- Magali IRLA (Immune tolerance and T cell differentiation, CIML, Marseille, France)
 Thymic Central T Cell Tolerance: From Age-Related Involution to Immune Rejuvenation
Selected short oral presentations
- P1-01 - Meryem ALOULOU (INFINITY, INSERM UMR1291 – CNRS UMR5051 – University of Toulouse, Toulouse, France)
 Follicular Regulatory T Cells: Unexpected Allies of Neuroinflammation
- P1-02 - Claire SOUDAIS (UMR1163, Institut Imagine, Paris, France)
 Inhibition of the CTP synthase 1 prevents GVHD and delays skin graft rejection revealing distinct allo-T-cell responses
- P1-03 - Emeline PAPILLON (U932, Institut Curie, Paris, France)
 How do transposable elements shape T cell thymic selection?
Foyers - Levels S2-S3POSTER SESSION 1 - odd-numbered
Foyer - Level S2E-POSTER SESSION 1
Chair: Fabienne HASPOT (Nantes, France)
See the list of posters presented and the order of presentation
Foyer - Level S2E-POSTER SESSION 2
Chair: Rami BECHARA (Le Kremlin-Bicêtre, France)
See the list of posters presented and the order of presentation
Foyers - Levels S1-S2-S3 Lunch - Coffee - Visit of exhibition & Posters
Salle Louis Armand Ouest - Level S3JOURNÉE FÉDÉRATION D’IMMUNOLOGIE MÉDICALE
 
  
      
      Thérapies cellulaires innovantes dans la prévention de la GVH après allogreffe de cellules souches hématopoiétiques
Thérapies cellulaires innovantes dans la prévention de la GVH après allogreffe de cellules souches hématopoiétiques
Modérateurs : Stéphanie NGUYEN (Paris, France) & Jean-Hugues DALLE (Paris, France)
- Étienne DAGUINDAU (Besançon, France)  Physiopathologie de la GVH aigue et prévention en pratique courante Physiopathologie de la GVH aigue et prévention en pratique courante
- Mathieu LECLERC (Créteil, France)
 T régulateurs en prévention de la GVH chez l’homme
- Federico SIMONETTA (Genève, Suisse)
 Lymphocytes iNKT murins et modulation des effets GVH/GVL
- Marie-Thérèse RUBIO (Nancy, France)
 Lymphocytes iNKT humains et leur développement clinique dans l’allogreffe de CSH
- Maud D’AVENI-PINEY (Nancy, France)
 Cellules myéloides suppressives (MDSC) dans la greffe de CSH
- Cécile POCHON (Nancy, France)
 Cellules souches stromales mésenchymateuses (CSM) : comment optimiser leur utilisation pour prévenir la GVH ?
- Table ronde
PARALLEL SESSIONS
Salle Louis Armand Est - Level S3SP1 - Germinal Centers Club
Chairs: Carole LE COZ (Toulouse, France) & Céline DELALOY (Rennes, France)
- Pierre	MILPIED (Integrative B cell immunology, CIML, Marseille, France)
 Pre-plasma cells proliferate and differentiate at the germinal center-medulla interface of antigen-draining lymph nodes
- Johanne	JACOBSEN (Rikshospitalet, University of Oslo, Norway)
 Title upcoming
Selected short oral presentations
- SP1-01 - Yoann MISSOLO (INSERM U1330, Institut Curie, Paris, France)
 CD4+ T Cells Response to Tumor Invasion in Lymph Nodes
- SP1-02 - Emma VALDEVIT (Toulouse institute for infectious and inflammatory diseases, Toulouse, France)
 Human T follicular regulatory cells are composed by two layers of heterogeneity
- SP1-03 - Robert PHILIPPE (Laboratoire Adhesion et Inflammation, INSERM-CNRS-Aix-Marseille Université, Marseille, France)
 Mechanical force resistance rather than affinity as a selection factor driving antibody maturation in secondary lymphoid tissues
Amphi. Gaston Berger - Level S2SP2 - Inborn errors of immunity Club
Chairs: Emmanuel MARTIN (Paris, France) & Tom LE VOYER (Paris, France)
- Vivien	BÉZIAT (Human Genetics of Infectious diseases, Imagine institute, Paris, France)
 Genetic Determinants of Severe Cutaneous Oncoviral Infections
- Filomeen HAERYNCK (University of Ghent, Belgium)
 Title upcoming
Selected short oral presentations
- SP2-04 - Jean Sebastien DIANA (Department of Biotherapy, Necker Hospital (APHP), Paris, France)
 Gene therapy for Artemis deficiency: the results of the French ARTEGENE 2 Phase I/II clinical trial
- SP2-05 - Hailun	LI (HGID, Institut Imagine, Paris, France)
 Syndromic severe combined immunodeficiency in children with a complete form of inherited JAK1 deficiency
- SP2-06 - Nicolas AYAS (U1151, Institut Necker Enfants Malades, Paris, France)
 A neomorphicIRF4 variant disrupts human Treg biology in Primary Antibody deficiency-associated IBD
Salle 2 - Level S3SP3 - Career development (Young) Club
Chairs: Marie-Astrid BOUTET (Nantes, France) & Joaquin PELLEGRINI (France)
- Julie FLOCH (Association Bernard Gregory (ABG) - Responsable Formation et Accompagnement) & Shahul MOUHAMAD (Miltenyi Biotec - Marketing manager)
 A wide range of opportunities for PhDs
- Paola GARDELLIN (Présidente fondatrice de REVEALIS - Coach professionnel)
 From researcher to entrepreneur: is Women Leadership different from Men’s?
- Renaud POURPRE (Fondateur du collectif Exaltia - 
                Science communicator)
 Tips for becoming a part-time science communicator
- Round-table discussion: Julie FLOCH, Paola GARDELLIN, Renaud POURPRE & Shahul MOUHAMAD
PARALLEL SESSIONS
Amphi. Gaston Berger - Level S2SP4 - Immunometabolism
Chairs: Mehdi BENAMAR (Boston, USA) & Romain RONCAGALLI (Marseille, France)
- Stefanie	WCULEK (Institute for Research in Biomedicine, Barcelona, Spain)
 How innate immune cells adapt to environment and function: diverse tales of mitochondria
- Linda SINCLAIR (University of Dundee, UK)
 Fuelling T cells -> Proteostasis in T cells
Selected short oral presentations
- SP4-07 - Axelle PENC (Institut Necker Enfants Malades, Paris, France)
 The innate immune system contributes to the development of Pompe disease and represents an efficient therapeutic target
- SP4-08 - Bastien AZNAR (Institut Necker Enfants-Malades, Paris, France)
 The Histone Demethylase KDM6B Governs the LYVE1+ Perivascular Macrophage Phenotype to Control Adipose Tissue Expandability
- SP4-09 - Margaux SARRET (Sorbonne Université, Inserm U1135, CIMI, Paris, France)
 Age-Dependent Immunometabolism: Energetic Profiles of Lymphocytes and Monocytes
Salle Louis Armand Est - Level S3SP5 - Aging/senescence
Chairs: Bruno LUCAS (Paris, France) & Julie DÉCHANET-MERVILLE (Bordeaux, France)
- Jörg	GORONZY  (University of Stanford, CA, USA)
 TCF1 and HELIOS – Goddesses of T-cell youth
- María MITTELBRUNN  (Centro de Biologia Molecular - UAM, Madrid, Spain)
 Unlocking healthy aging through the immune system
Selected short oral presentations
- SP5-10 - Romain TORRES (INFINITY, INSERM UMR1291, Toulouse, France)
 Aging predisposes naive CD4+ T cell to a pro-inflammatory Th1 fate
- SP5-11 - Bruno MARTIN (Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France)
 IFN-α-driven down-regulation of Foxo1 induces functional remodeling of the peripheral γδ T-cell compartment with Age
- SP5-12 - Manon CHAUVIN (Sorbonne Université, Inserm U1135, CIMI-Paris, Paris, France)
 From Immune Activation to Immune Decline: Neopterin in the Aging Process
Foyers - Levels S1-S2-S3Coffee break - Visit of exhibition - Posters
PARALLEL SESSIONS
Salle Louis Armand Est - Level S3SP6 - Neuroimmunology
Chairs: Nicolas FAZILLEAU (Toulouse, France) & Anne ASTIER (Toulouse, France)
- Marina	RUBIO (Physiopathology and Imaging of Neurological Disorders, GIP Cyceron, Normandie University, Caen, France)
 BAMs take the lead: orchestrating neuroinflammation after ischemic stroke
- Mikael SIMONS (Institute of Neuronal Cell Biology, Munich, Germany)
 Myelin pathology & neuroinflammation in the CNS
Selected short oral presentations
- SP6-13 - Mehdi BENAMAR (Division of Immunology, Boston Children’s Hospital, Boston, Massachusetts, USA)
 Notch3+ Regulatory T cells Drive Autoimmune Neuroinflammation in Multiple Sclerosis
- SP6-14 - Irini EVNOUCHIDOU (Centre de Recherche sur l’Inflammation, INSERM U1149, Université Paris Cité, Paris, France)
 A new transcription factor regulating neuroinflammation
- SP6-15 - Nicolas BLANCHARD (Inserm UMR1291 - CNRS UMR5051 - University of Toulouse, Toulouse Institute for Infectious and Inflammatory diseases - Infinity, Toulouse, France)
 Immune evasion by Toxoplasma gondii through epigenetic suppression of neuronal MHC I presentation
Amphi. Gaston Berger - Level S2SP7 - TCR/BCR Signalisation
Chairs: Laurence BATAILLE (Paris, France) & Romain RONCAGALLI (Marseille, France)
- Renaud LESOURNE (Integrative mapping of lymphocyte signaling and function, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France)
 Fine tuning T cell responses through checkpoint regulation and diversification
- Pieta MATTILA (University of Turku, Finland)
 Septin7 regulates the formation of the B cell immune synapse and B cell responses
Selected short oral presentations
- SP7-16 - Hermine FERRAN (U932, Institut Curie, Paris, France)
 The MARK2 kinase acts as a gatekeeper of CD28-dependent co-stimulation in T cells
- SP7-17 - Audrey PAGE (Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France)
 Disruption of Intracellular Immune Checkpoints Lowers the Activation Threshold of TCR-T Cells
- SP7-18 - Manuel D. DIAZ-MUNOZ (Inserm U1291, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse, France)
 Post-transcriptional regulation of the B-cell receptor is instrumental for innate B cell maintenance and regulatory function
 
    
  